Harvey Capital Management’s Merck MRK Stock Holding History

Harvey Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$301K	Hold	2,500	–	–	0.07%	71
2025 Q4	$263K	Hold	2,500	–	–	0.06%	71
2025 Q3	$210K	Hold	2,500	–	–	0.04%	83
2025 Q2	$205K	Sell	2,500 -300	-11%	-$23.8K	0.05%	77
2025 Q1	$251K	Hold	2,800	–	–	0.07%	75
2024 Q4	$279K	Hold	2,800	–	–	0.07%	76
2024 Q3	$318K	Hold	2,800	–	–	0.08%	66
2024 Q2	$347K	Hold	2,800	–	–	0.09%	70
2024 Q1	$369K	Hold	2,800	–	–	0.11%	65
2023 Q4	$305K	Hold	2,800	–	–	0.1%	64
2023 Q3	$288K	Hold	2,800	–	–	0.1%	65
2023 Q2	$323K	Hold	2,800	–	–	0.12%	69
2023 Q1	$298K	Hold	2,800	–	–	0.12%	71
2022 Q4	$311K	Hold	2,800	–	–	0.13%	69
2022 Q3	$241K	Hold	2,800	–	–	0.1%	70
2022 Q2	$255K	Hold	2,800	–	–	0.1%	71
2022 Q1	$229K	Sell	2,800 -38,585	-93%	-$3.04M	0.07%	73
2021 Q4	$3.17M	Buy	41,385 +50	+0.1%	+$3.98K	0.98%	37
2021 Q3	$3.1M	Sell	41,335 -1,100	-3%	-$83.7K	1.06%	33
2021 Q2	$3.3M	Sell	42,435 -3,425	-7%	-$255K	1.09%	33
2021 Q1	$3.37M	Buy	45,860 +943	+2%	+$69.6K	1.22%	32
2020 Q4	$3.5M	Buy	44,917 +105	+0.2%	+$8.03K	1.42%	26
2020 Q3	$3.55M	Sell	44,812 -441	-1%	-$34.5K	1.58%	21
2020 Q2	$3.34M	Buy	+45,253	New	+$3.41M	1.65%	20
2020 Q1	–	Sell	-2,620	Closed	-$227K	–	77
2019 Q4	$227K	Hold	2,620	–	–	0.1%	73
2019 Q3	$210K	Hold	2,620	–	–	0.1%	73
2019 Q2	$209K	Hold	2,620	–	–	0.1%	76
2019 Q1	$207K	Buy	+2,620	New	+$196K	0.1%	75

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harvey Capital Management's MRK Position: Q1 2026 in Review

Harvey Capital Management held its Merck (MRK) position steady in Q1 2026 at 2,500 shares worth $301K. The position accounts for 0.07% of the portfolio, ranked #71.

Harvey Capital Management first reported a position in MRK in Q1 2019 and has held it in 28 quarters since. The position peaked at $3.55M in Q3 2020. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Harvey Capital Management held 2,500 shares of Merck worth $301K as of Q1 2026.
Harvey Capital Management left its Merck share count unchanged in Q1 2026.
Merck made up 0.07% of Harvey Capital Management's portfolio in Q1 2026, its #71 holding.
Harvey Capital Management first reported a position in Merck in Q1 2019 and has held it in 28 quarters since.
Harvey Capital Management's Merck position peaked at $3.55M in Q3 2020.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Harvey Capital Management's 13F filing for Q1 2026, filed 11 May 2026.